However, the finding that HO recurred at an existing site after surgery suggests that further study is needed before IL-1 inhibitors could be considered for prophylactic use in patients with FOP undergoing surgery. The gene discussed is IL1B; the disease is fibrodysplasia ossificans progressiva.